Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients

1 Aug 2018

Abstract excerpt

Protocadherin10 (PCDH10), a member of the nonclustered protocadherin family, functions as a tumor suppressor in many cancers. The aim of this study was to evaluate the expression level and prognostic value of PCDH10 in hepatocellular carcinoma (HCC) patients.Quantitative real-time polymerase chain reaction was used to analyze the expression level of PCDH10 in HCC tissues and adjacent nontumor tissues. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to MicroRNA in disease regulation
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30170418
DOI: 10.1097/md.0000000000012055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patientsPMID 30170418Read ↗

Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosisSemantic proximity Read ↗

Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancerSemantic proximity Read ↗

Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinomaSemantic proximity Read ↗

Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer.Semantic proximity Read ↗

PCDH10, a novel p53 transcriptional target in regulating cell migrationSemantic proximity Read ↗

Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancerSemantic proximity Read ↗

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancerSemantic proximity Read ↗

Clinical Significance of the Methylated Cytosine-Phosphate-Guanine Sites of Protocadherin-10 Promoter for Evaluating the Prognosis of Gastric CancerSemantic proximity Read ↗

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphomaSemantic proximity Read ↗

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.Semantic proximity Read ↗

Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.